To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: E. coli disulfide bond formation protein B (DsbB)

Infectious disease

INDICATION: Gram-negative bacterial infection

In vitro studies suggest DsbB inhibitors could help treat Gram-negative bacterial infections.

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE